BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Ovid Realigns C-Suite After Throwing in the Towel on Phase III Candidate

  This week’s announcement includes a step to the side for CMO Amit Rakhit, who will transition to the biotech’s advisory board.

  July 9, 2021

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Policy

  Noting Delta Variant, Pfizer/BioNTech Plan to Ask FDA for Booster Shot EUA

  The two companies said a booster dose given six months after the second dose had a consistent tolerability profile while still creating high immune responses against the Alpha and Beta variant.

  July 9, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Deals

  Purdue Pharma Reorganization Gains Support from 15 States

  The move by the 15 states’ attorneys general comes about a month ahead of a court hearing set for Aug. 5.

  July 9, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  Philip Morris Makes $1.44 Billion Bid for UK Inhaled Drug Specialist Vectura Group

  Philip Morris will acquire Vectura to gain access to its inhaled drug formulas to bolster its Beyond Nicotine strategy.

  July 9, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Job Trends

  Chicago Biopharma Builds Commercial Facility in China to Focus on Antibody Development

  Sparx Therapeutics is expanding its operations into Yangzhou, China, with the imminent construction of a 1.2 million square foot facility for its commercial production.

  July 9, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  Clinical Catch-Up: July 5-9

  Last week presented a fair number of clinical trial news. Read on for more information.

  July 9, 2021

   · 

  6 min read

   · 

  Mark Terry
• 

  Deals

  Sight Sciences Targets $160.5 Million IPO

  It plans to trade under the SGHT ticker symbol.

  July 9, 2021

   · 

  2 min read

   · 

  Mark Terry
• 

  Pharm Country

  Pharm Country Hotbed Continues to Prove it is Home to a Hot Job Market

  BioSpace’s Pharm Country Hotbed ranges from Connecticut, New York, New Jersey, Pennsylvania and Rhode Island.

  July 9, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Business

  Inclusion and Diversity is Paramount to Sana’s Patient-Centric Culture

  Sana Biotechnology, a gene and cell therapy hybrid whose mission is to create and deliver engineered cells as medicines for patients, puts the “I” first in Inclusion, Diversity and Equity (IDE).

  July 9, 2021

   · 

  5 min read

   · 

  Heather McKenzie
• 

  Business

  Muna Therapeutics Raises $73 Million to Advance Neurodegenerative Disease Focus

  The company launches with the new funding to advance its focus on first-in-class small molecule therapies for neurodegenerative diseases.

  July 9, 2021

   · 

  2 min read

   · 

  Brandon May